Nasdaq : Delisting of Securities of BIND Therapeutics, Inc., InterCloud Systems, Inc., Echo Therapeutics, Inc., 1347 Capital Corp., and EPIRUS Biopharmaceuticals, Inc. from The Nasdaq Stock Market
September 23, 2016 at 04:18 pm EDT
Share
NEW YORK, Sept. 23, 2016 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of BIND Therapeutics, Inc. BIND Therapeutics, Inc.'s stock was suspended on August 01, 2016 and has not traded on Nasdaq since that time.
Nasdaq also announced that it will delist the common stock and warrant of InterCloud Systems, Inc. InterCloud Systems, Inc's common stock and warrant were suspended on August 31, 2016 and have not traded on Nasdaq since that time.
Nasdaq also announced that it will delist the common stock of Echo Therapeutics, Inc. Echo Therapeutics, Inc.'s stock was suspended on July 12, 2016 and has not traded on Nasdaq since that time.
Nasdaq also announced that it will delist the common stock, warrant, unit and right of 1347 Capital Corp. 1347 Capital Corp.'s common stock, warrant, unit and right were suspended on July 12, 2016 and have not traded on Nasdaq since that time.
Finally, Nasdaq announced that it will delist the common stock of EPIRUS Biopharmaceuticals, Inc. EPIRUS Biopharmaceuticals, Inc.'s stock was suspended on August 04, 2016 and has not traded on Nasdaq since that time.
Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delisting for each of these companies. The delistings become effective ten days after the Form 25 is filed. For news and additional information about the companies, including the basis for the delistings and whether the companies' securities are trading on another venue, please review the companies' public filings or contact the company directly.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq's rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: http://www.cchwallstreet.com/NasdaqTools/bookmark.asp?id=nasdaq-rule_5800&manual=/nasdaq/main/nasdaq-equityrules/.
NDAQO
NASDAQ OMX Group Inc. published this content on 23 September 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 23 September 2016 20:18:05 UTC.
Original documenthttp://www.nasdaqomx.com/newsroom/pressreleases/pressrelease?messageId=1491292&displayLanguage=en
Public permalinkhttp://www.publicnow.com/view/8AAD9C1C5AA05D3B0E6A9415829A8CACD510A422
Nasdaq, Inc. is one of the world's leaders Stock Exchanges. Net sales by activity break down as follows:
- trading services (63%): operations execution and managing on shares, derivatives, obligations, commodities, structured products and exchange-traded funds;
- sale of data and market indexes (18.3%);
- listing services (10.4%): financial instruments listing management;
- market software sale (7.9%). Besides, the group offers solutions of brokerage, storage, clearing and settlement of securities, information surveillance and delivery;
- other (0.4%).
The United States account for 81.9% of net sales.
Nasdaq : Delisting of Securities of BIND Therapeutics, Inc., InterCloud Systems, Inc., Echo Therapeutics, Inc., 1347 Capital Corp., and EPIRUS Biopharmaceuticals, Inc. from The Nasdaq Stock Market